Clear Point Advisors’s AbbVie ABBV Stock Holding History

Clear Point Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$234K	Buy	+895	New	+$229K	0.16%	123
2024 Q4	–	Sell	-489	Closed	-$96.5K	–	107
2024 Q3	$96.5K	Buy	489 +1	+0.2%	+$187	0.07%	151
2024 Q2	$83.7K	Buy	488 +1	+0.2%	+$166	0.07%	154
2024 Q1	$88.7K	Buy	487 +1	+0.2%	+$172	0.07%	153
2023 Q4	$75.4K	Buy	+486	New	+$70.9K	0.07%	154

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Clear Point Advisors's ABBV Position: Q3 2026 in Review

Clear Point Advisors opened a new position in AbbVie (ABBV) in Q3 2026: 895 shares worth $234K. The stake represents 0.16% of the portfolio and ranks #123 among its holdings. This is a return to the name: Clear Point Advisors previously reported a position in ABBV as recently as Q3 2024.

Clear Point Advisors first reported a position in ABBV in Q4 2023 and has held it in 5 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Clear Point Advisors held 895 shares of AbbVie worth $234K as of Q3 2026.
AbbVie was a new Clear Point Advisors position in Q3 2026.
AbbVie made up 0.16% of Clear Point Advisors's portfolio in Q3 2026, its #123 holding.
Clear Point Advisors first reported a position in AbbVie in Q4 2023 and has held it in 5 quarters since.
1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Clear Point Advisors's 13F filing for Q3 2026, filed 30 Oct 2026.